Literature DB >> 22227487

Polymorphisms in inflammasome' genes and susceptibility to HIV-1 infection.

Alessandra Pontillo1, Telma M Oshiro, Martina Girardelli, Anselmo J Kamada, Sergio Crovella, Alberto J S Duarte.   

Abstract

The involvement of inflammasome genes in the susceptibility to HIV-1 infection was investigated. Twelve single nucleotide polymorphisms within NLRP1, NLRP3, NLRC4, CARD8, CASP1, and IL1B genes were analyzed in 150 HIV-1-infected Brazilian subjects and 158 healthy controls. The 2 polymorphisms rs10754558 in NLRP3 and rs1143634 in IL1B were significantly associated to the HIV-1 infection. These findings supported the previously hypothesized involvement of NALP3-inflammasome in HIV-1 pathogenesis, underlining once more the key role of inflammation and innate immunity in the susceptibility to HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22227487     DOI: 10.1097/QAI.0b013e3182392ebe

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  32 in total

1.  NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients.

Authors:  Chao Zhang; Jin-Wen Song; Hui-Huang Huang; Xing Fan; Lei Huang; Jian-Ning Deng; Bo Tu; Kun Wang; Jing Li; Ming-Ju Zhou; Cui-Xian Yang; Qi-Wen Zhao; Tao Yang; Li-Feng Wang; Ji-Yuan Zhang; Ruo-Nan Xu; Yan-Mei Jiao; Ming Shi; Feng Shao; Rafick-Pierre Sékaly; Fu-Sheng Wang
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

2.  The association of NLRP3 and TNFRSF1A polymorphisms with risk of ankylosing spondylitis and treatment efficacy of etanercept.

Authors:  Shengchun Zhao; Hongwei Chen; Guolin Wu; Chen Zhao
Journal:  J Clin Lab Anal       Date:  2017-01-23       Impact factor: 2.352

3.  Psoriasis risk SNPs and their association with HIV-1 control.

Authors:  Joanne Nititham; Rashmi Gupta; Xue Zeng; Wendy Hartogensis; Douglas F Nixon; Steven G Deeks; Frederick M Hecht; Wilson Liao
Journal:  Hum Immunol       Date:  2016-10-31       Impact factor: 2.850

4.  NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn's disease (CD), in Chinese Han population.

Authors:  Hong-xin Zhang; Zheng-ting Wang; Xiong-xiong Lu; Yan-gui Wang; Jie Zhong; Jie Liu
Journal:  Inflamm Res       Date:  2014-10-09       Impact factor: 4.575

5.  Inflammation-related genes are associated with epigenetic aging in HIV.

Authors:  Erin E Sundermann; Mariam A Hussain; David J Moore; Steven Horvath; David T S Lin; Michael S Kobor; Andrew Levine
Journal:  J Neurovirol       Date:  2019-07-08       Impact factor: 2.643

6.  HIV infection modulates IL-1β response to LPS stimulation through a TLR4-NLRP3 pathway in human liver macrophages.

Authors:  Lumin Zhang; Arevik Mosoian; Myron E Schwartz; Sander S Florman; Ganesh Gunasekaran; Thomas Schiano; M Isabel Fiel; Wei Jiang; Qi Shen; Andrea D Branch; Meena B Bansal
Journal:  J Leukoc Biol       Date:  2019-02-18       Impact factor: 4.962

7.  Interleukin gene polymorphisms and susceptibility to HIV-1 infection: a meta-analysis.

Authors:  Chrissa G Tsiara; Georgios K Nikolopoulos; Niki L Dimou; Katerina G Pantavou; Pantelis G Bagos; Benedicta Mensah; Michael Talias; Georgia G Braliou; Dimitra Paraskeva; Stefanos Bonovas; Angelos Hatzakis
Journal:  J Genet       Date:  2018-03       Impact factor: 1.166

8.  Tissue-specific expression pattern and histological distribution of NLRP3 in Chinese yellow chicken.

Authors:  Jinhui Ye; Meng Yu; Kaizhao Zhang; Jianxin Liu; Qingnan Wang; Pan Tao; Kun Jia; Ming Liao; Zhangyong Ning
Journal:  Vet Res Commun       Date:  2015-08-06       Impact factor: 2.459

9.  Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS.

Authors:  John G Walsh; Stacey N Reinke; Manmeet K Mamik; Brienne A McKenzie; Ferdinand Maingat; William G Branton; David I Broadhurst; Christopher Power
Journal:  Retrovirology       Date:  2014-05-13       Impact factor: 4.602

Review 10.  The expanding role of NLRs in antiviral immunity.

Authors:  Christopher Lupfer; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.